Journal of Clinical and Experimental Epidemiology Research

Journal of Clinical and Experimental Epidemiology Research

Open Access
ISSN: 3070-3956
Original Research Article

High Rates of Viral Suppression in Pregnant Women Receiving Antiretroviral Therapy at Selected Government Health Facilities: A Retrospective Cohort Study

Authors: Zenebe Minda, Lemessa Oljira.

DOI: 10.33425/3070-3956.1005


Abstract

Background: The attainment of viral suppression (VS) has not only extended the life expectancy of HIV-infected pregnant women (HIPW) but also has significantly reduced the rate of HIV vertical HIV transmission (VT). We to ascertain the rate of VS among HIPW at health facilities.

Methods: A retrospective cohort study was carried out from June 1, 2016, to May 31, 2024. Data were extracted via document review using a structured and pretested checklist.

Results: The overall VS rate was 392 (93.60%). Poor adherence to ART and a CD4 cell count of 350 or fewer were associated with a decreased likelihood of achieving VS. The odds of poor adherence to ART and a CD4 cell count of 350 or fewer were both 0.1 at 6 months after initiating ART (adjusted odds ratio [aOR] 0.1, 95% confidence interval [CI] 0.2-0.2) and (aOR 0.1, 95% CI 0.1-0.3), respectively. Employment increased the odds of VS in women by 4.1 times (aOR 4.1, 95% CI 1.1-14.9) at 6 months after ART initiation compared to being a housewife.

Conclusion: The VS rates observed in the study facilities are promising but remain significantly below the targets set for achieving epidemic control. Therefore, intensified efforts are crucial to attain the goal of HIV epidemic control.

View / Download PDF
Citation: Zenebe Minda, Lemessa Oljira. High Rates of Viral Suppression in Pregnant Women Receiving Antiretroviral Therapy at Selected Government Health Facilities: A Retrospective Cohort Study. 2025; 1(1). DOI: 10.33425/3070-3956.1005
Editor-in-Chief
Marcelo Aldaz
Marcelo Aldaz
Department of Epigenetics and Molecular Carcinogenesis | The University of Texas MD Anderson Cancer Center

View full editorial board →
Journal Metrics
Impact Factor 1.6*
Acceptance Rate 72%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days